ALB and hepatocellular carcinoma: In addition, considering that long-term albumin administration improves survival in patients with cirrhosis [42,43,44,45], such treatment may also be a promising therapeutic option for preventing HCC recurrence in pre-S2 mutant-positive HCC patients who have a low serum albumin level.